lirilumab

Innate shares crushed on second big setback for Bristol-Myers partnered lirilumab
Endpoints
Sat, 11/25/17 - 12:32 pm
Innate Pharma
Bristol-Myers Squibb
lirilumab
acute myeloid leukemia
Bristol-Myers, Innate's Lirilumab Fails Trial (BMY)
Investopedia
Mon, 02/6/17 - 11:16 am
Bristol-Myers Squibb
Innate Pharma S.A.
lirilumab
acute myeloid leukemia